Document Detail


The effect of thyroxine-suppressive therapy in patients with solitary non-toxic thyroid nodules -- a randomised, double-blind, placebo-controlled study.
MedLine Citation:
PMID:  16409424     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The efficacy of thyroxine (T(4)) for solitary non-toxic thyroid nodule remains uncertain. In this study, 60 patients with solitary non-toxic thyroid nodule were divided randomly into two groups. Group I (n = 30) received thyroxine 100 microg/day for 6 months and group II (n = 30) received placebo. The volume of the thyroid nodules in 11 patients decreased more than 50% after thyroxine therapy (36.7%, responders). In these 11 patients, the mean serum thyroglobulin level decreased significantly (340 +/- 115 to 162 +/- 86 microg/l, p < 0.01). Compared with the non-responders (n = 19, 63.3%), the serum thyroglobulin level before treatment was significantly higher (340 +/- 115 vs. 220 +/- 102 microg/l, p < 0.05). Thyroxine-suppressive therapy is proved as a useful tool in reducing nodule size in some patients with solitary thyroid nodules. The patients with a higher serum thyroglobulin level generally respond better to thyroxine-suppressive therapy.
Authors:
C-C Tsai; D Pei; Y-J Hung; T-F Wang; W-C Tsai; C-Y Yao; M-C Hsieh; S-W Kuo
Related Documents :
21385954 - Timing of spawning and early development of palythoa tuberculosa (anthozoa, zoantharia,...
7066734 - Prediction of the need for postoperative mechanical ventilation in myasthenia gravis: t...
20596784 - Prophylactic central neck dissection and local recurrence in papillary thyroid cancer: ...
16928524 - Thoracoscopic thymectomy mid-term results.
18354844 - Natalizumab: new drug. multiple sclerosis: risky market approval.
23888194 - Response of blood pressure after percutaneous transluminal renal artery angioplasty and...
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  International journal of clinical practice     Volume:  60     ISSN:  1368-5031     ISO Abbreviation:  Int. J. Clin. Pract.     Publication Date:  2006 Jan 
Date Detail:
Created Date:  2006-01-13     Completed Date:  2006-02-14     Revised Date:  2007-02-14    
Medline Journal Info:
Nlm Unique ID:  9712381     Medline TA:  Int J Clin Pract     Country:  England    
Other Details:
Languages:  eng     Pagination:  23-6     Citation Subset:  IM    
Affiliation:
Division of Endocrinology and Metabolism, Department of Internal Medicine, Buddhist Tzu-Chi General Hospital, Tzu-Chi University, Hualien, Taiwan, ROC.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Double-Blind Method
Female
Humans
Male
Prospective Studies
Thyroid Nodule / drug therapy*
Thyrotropin
Thyroxine / antagonists & inhibitors*
Chemical
Reg. No./Substance:
7488-70-2/Thyroxine; 9002-71-5/Thyrotropin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Long-term management of patients with symptoms of gastro-oesophageal reflux disease -- a Norwegian r...
Next Document:  Randomised phase II trial of gemcitabine and paclitaxel second-line chemotherapy in patients with tr...